Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MET | P08581 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 2/20 | 0.45 |
| ▸ | SMURF1 | Q9HCE7 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3398194 | 0.89 | TP53 (0.55) | TP53PTGS2MAPTMETSMN1; SMN2 | |
| SCHEMBL3405011 | 0.82 | MET (0.59) | TP53PTGS2MAPTMETSMN1; SMN2 | |
| SCHEMBL3405207 | 0.81 | GRM5 (0.67) | TP53PTGS2MAPTSMN1; SMN2RIPK1 | |
| SCHEMBL3402699 | 0.80 | TP53 (0.57) | TP53PTGS2MAPTMETSMN1; SMN2 | |
| SCHEMBL7987917 | 0.80 | TP53 (0.57) | TP53PTGS2MAPTMETSMN1; SMN2 | |
| SCHEMBL3402289 | 0.78 | GRM5 (0.67) | TP53PTGS2MAPTMETSMN1; SMN2 | |
| SCHEMBL13754541 | 0.78 | PTGS2 (0.71) | TP53PTGS2MAPTMETSMN1; SMN2 | |
| SCHEMBL3400890 | 0.77 | SMN1; SMN2 (0.65) | TP53PTGS2MAPTMETSMN1; SMN2 | |
| SCHEMBL3401188 | 0.76 | TP53 (0.59) | TP53PTGS2MAPTSMN1; SMN2GRM5 | |
| SCHEMBL8000300 | 0.75 | GRM5 (0.69) | TP53PTGS2MAPTMETSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2252599-A1 | TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY | Glaxo Group Limited (GB) | 2010-11-24 | — | — | EP | disclosed |
| WO-2009115486-A1 | TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY | GLAXO GROUP LIMITED (GB) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009115486-A1 | TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY | GLAXO GROUP LIMITED (GB) | 2009-09-24 | — | — | WO | disclosed |